Greenberg Traurig Represents NeoImmuneTech, Inc. in KOSDAQ IPO
April 01, 2021Global law firm Greenberg Traurig, LLP represented NeoImmuneTech, Inc., a clinical-stage T cell-focused biopharmaceutical company, in connection with its initial public offering (IPO) on the Korea Exchange (KOSDAQ).
